ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
0,005
0,00
(0,00%)
Geschlossen 01 Februar 10:00PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,005
Gebot
0,005
Fragen
0,005
Volumen
-
0,00 Tagesbereich 0,00
0,005 52-Wochen-Bereich 0,01
Marktkapitalisierung
Handelsende
0,005
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
77.187.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-0,08
Erlöse
989k
Nettogewinn
-6,07M

Über Avivagen Inc

Sektor
Coml Physical, Biologcl Resh
Branche
Pharmaceutical Preparations
Hauptsitz
Ottawa, Ontario, Can
Gegründet
2012
Avivagen Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX Venture Börse with ticker VIV. The last closing price for Avivagen was $0,01. Over the last year, Avivagen shares have traded in a share price range of $ 0,005 to $ 0,01.

Avivagen currently has 77.187.000 shares in issue. The market capitalisation of Avivagen is $385.935,00 . Avivagen has a price to earnings ratio (PE ratio) of 0.00.

VIV Neueste Nachrichten

Avivagen Announces Appointment of James Nickerson as President

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that...

Avivagen Continues Market Growth with New Customer Win in Western Mexico

Order signifies important growth in key production territories in Mexico Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing...

Avivagen Announces Recurring Order for OxC-betaTM Livestock

Largest purchase amount and longest duration purchase to-date Four tonne per month order secured Order follows five successful OxC-betaTM Livestock commercial trials conducted with various...

Avivagen Inc. to Issue Shares to Holders of Debentures in Lieu of Annual Maintenance Fee

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”) announces that a total of 3,931 common shares will be issued at the rate of $0.58 per share to satisfy the maintenance fee...

Avivagen anuncia la inminente publicación de una investigación que destaca los beneficios de OxC-betaTM Livestock para las ...

Dicho estudio se publicará próximamente en la prestigiosa revista Poultry Science. Poultry Science es una revista internacionalmente reconocida, considerada como la fuente autorizada de una...

Avivagen Announces Upcoming Research Publication Highlighting The Benefits Of OxC-betaTM Livestock for Broiler Poultry

Study to be published soon in leading peer-reviewed journal Poultry Science. Poultry Science is an internationally renowned journal, known as the authoritative source for a broad range of...

Avivagen confía en Meyenberg International Group para dirigir sus actividades de expansión en América Central y del Sur

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) («Avivagen»), empresa de ciencias biológicas dedicada a desarrollar y comercializar productos para el ganado, los animales de compañía y aplicaciones humanas...

Avivagen Selects Meyenberg International Group to Spearhead Expansion Efforts in Central and South America

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that...

Avivagen anuncia la publicación de su OxC-beta en Nueva Zelanda™ Ensayo realizado en ganado lechero para uso contra la mas...

Avivagen Inc. (TSXV:VIV) (“Avivagen”) es una empresa de ciencias biológicas dedicada a desarrollar y comercializar productos para ganado, animales de compañía y aplicaciones humanas que aumentan...

Avivagen anuncia un pedido de seis toneladas de OxC-beta™ Livestock de un nuevo cliente en México

Este pedido continuo y de gran volumen complementa al pedido anterior de diez toneladas de Industrias Melder, un cliente establecido. Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), una...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.0050.0050.00500CS
4000.0050.0050.00500CS
12000.0050.0050.00500CS
26000.0050.0050.00500CS
52000.0050.010.00519310.005CS
156-0.25-98.03921568630.2550.2650.005415010.08255903CS
260-0.615-99.19354838710.620.780.005508200.31291285CS

VIV - Frequently Asked Questions (FAQ)

What is the current Avivagen share price?
The current share price of Avivagen is $ 0,005
How many Avivagen shares are in issue?
Avivagen has 77.187.000 shares in issue
What is the market cap of Avivagen?
The market capitalisation of Avivagen is CAD 385,94k
What is the 1 year trading range for Avivagen share price?
Avivagen has traded in the range of $ 0,005 to $ 0,01 during the past year
What is the cash to sales ratio of Avivagen?
The cash to sales ratio of Avivagen is 0
What is the reporting currency for Avivagen?
Avivagen reports financial results in CAD
What is the latest annual turnover for Avivagen?
The latest annual turnover of Avivagen is CAD 989k
What is the latest annual profit for Avivagen?
The latest annual profit of Avivagen is CAD -6,07M
What is the registered address of Avivagen?
The registered address for Avivagen is 100 SUSSEX DRIVE, OTTAWA, ONTARIO, K1A 0R6
What is the Avivagen website address?
The website address for Avivagen is www.avivagen.com
Which industry sector does Avivagen operate in?
Avivagen operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
BYM.HBaymount Incorporated
$ 0,015
(200,00%)
102k
FBR.HFibre Crown Manufacturing Inc
$ 0,12
(140,00%)
10k
MPTH.HMapath Capital Corp
$ 0,035
(133,33%)
1.000
MMNMonarca Minerals Inc
$ 0,01
(100,00%)
10k
GETTGETT Gold Inc
$ 0,02
(100,00%)
1,1k
EKGCardioComm Solutions Inc
$ 0,01
(-50,00%)
79k
ADEAdex Mining Inc
$ 0,005
(-50,00%)
21,1k
MVYMoovly Media Inc
$ 0,005
(-50,00%)
1,3M
MURMurchison Minerals Ltd
$ 0,01
(-33,33%)
10k
AOROAloro Mining Corp
$ 0,01
(-33,33%)
59k
GXUGoviEx Uranium Inc
$ 0,035
(-30,00%)
50,83M
AISXAisix Solutions Inc
$ 0,05
(42,86%)
6,56M
CYGCygnus Metals Limited
$ 0,12
(-7,69%)
4,8M
GPUSAlset AI Ventures Inc
$ 0,105
(10,53%)
4,43M
QNCQuantum Emotion Corp
$ 0,81
(6,58%)
3,16M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock